Bure Equity AB (“Bure”) has divested 3,700,000 shares in Mycronic AB (“Mycronic”). The shares were sold to a price of SEK 235 per share, corresponding to a total sell down of approximately SEK 870 million. Following the share sale, Bure owns 22,617,163 shares in Mycronic corresponding to 23.1 per cent of the total number of outstanding shares. and votes. KANTER Advokatbyrå acted as legal advisor to Bure in the share sale.